monoethylglycinexylidide has been researched along with Hepatitis C in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Bac, C; Duca, F; Lecce, R; Livoli, D; Pasquazzi, C; Taliani, G | 1 |
| Shaw-Stiffel, TA; Ziebell, J | 1 |
| Alvarez, S; Borzone, S; Caglieris, S; Campo, N; Testa, R; Zentilin, P | 1 |
| Biceglia, O; De Biasio, MC; De Crescenzo, OD; Forte, GB; Minerva, A; Paceli, M; Rocco, P | 1 |
1 trial(s) available for monoethylglycinexylidide and Hepatitis C
| Article | Year |
|---|---|
[The peripheral blood lymphocyte subpopulations in chronic anti-HCV-positive liver disease: their significance and correlation with liver function].
Topics: Adult; Biopsy; Female; Hepatitis C; Hepatitis, Chronic; Humans; Lidocaine; Liver; Liver Cirrhosis; Lymphocyte Subsets; Male; Middle Aged | 1996 |
3 other study(ies) available for monoethylglycinexylidide and Hepatitis C
| Article | Year |
|---|---|
Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis.
Topics: Adult; Aged; Fatty Liver; Female; Hepatitis C; Humans; Lidocaine; Liver; Male; Middle Aged | 1995 |
Quantitative liver testing with MEG-X: more optimism?
Topics: Autoimmune Diseases; Biopsy; Hepatitis; Hepatitis C; Lidocaine; Liver; Reproducibility of Results | 1995 |
Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
Topics: Adult; Esophagitis, Peptic; Hepatitis C; Hepatitis, Chronic; Humans; Lidocaine; Male; Mixed Function Oxygenases; Omeprazole | 1994 |